Skip to main content
padlock icon - secure page this page is secure

Mutational analysis of IκBα in hematologic malignancies

Buy Article:

$42.00 + tax (Refund Policy)

The activation of the NF-κB family of transcription factors plays a crucial role in oncogenesis. The IκB family has the ability to retain the NF-κB in an inactive complex in the cytoplasm. Recently, mutations of the IκBα gene were found in Hodgkin's lymphoma, which allows NF-κB proteins to translocate into the nucleus in an active form. In this report, we describe a mutational analysis of IκBα for primary tumor cells obtained from patients with a variety of hematologic malignancies (acute myelogenous leukemia, chronic myelogenous leukemia, myelodysplastic syndrome, hairy cell leukemia, adult T-cell leukemia, and mantle cell lymphoma) as well as 15 leukemia, lymphoma, and myeloma cell lines (HL60, U937, HEL, K562, NALM1, Jurkat, JM, MOLT4, Raji, KS1, OKM2T, OKM3T, F6T, Su9T01, and C2-2). RT-PCR, followed by direct sequencing, was performed and all samples expressed IκBα. One missense mutation was identified in a primary effusion lymphoma cell line, KS1. However, NF-κB (p65) protein was absent from the nucleus of KS1 immunohistochemically, suggesting that the mutation did not alter the function of IκBα in this case. Taken together, although it is not clear whether normal IκBα protein was expressed in hematologic malignancies, mutations of IκBα could be rare events in these diseases, except for Hodgkin's lymphoma. Alterations of other members of NF-κB/ IκB family proteins might act on the development of hematologic malignancies.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Document Type: Research Article

Affiliations: Department of Internal Medicine, Division 1, Nihon University School of Medicine, Itabashi-ku, Tokyo 173-8610, Japan., Email: [email protected]

Publication date: January 1, 2003

More about this publication?
  • The International Journal of Molecular Medicine is a monthly, peer-reviewed journal devoted to the publication of high quality studies related to the molecular mechanisms of human disease. The journal welcomes research on all aspects of molecular and clinical research, ranging from biochemistry to immunology, pathology, genetics, human genomics, microbiology, molecular pathogenesis, molecular cardiology, molecular surgery and molecular psychology.

    The International Journal of Molecular Medicine aims to provide an insight for researchers within the community in regard to developing molecular tools and identifying molecular targets for the diagnosis and treatment of a diverse number of human diseases.
  • Editorial Board
  • Information for Authors
  • Submit a Paper
  • Subscribe to this Title
  • Information for Advertisers
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more